These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33918274)

  • 41. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
    Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
    Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects.
    Cardo LF; Coto E; Ribacoba R; Menéndez M; Moris G; Suárez E; Alvarez V
    J Mol Neurosci; 2014 Dec; 54(4):830-6. PubMed ID: 25284245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease.
    Yousefi M; Peymani M; Ghaedi K; Irani S; Etemadifar M
    Sci Rep; 2022 Feb; 12(1):2569. PubMed ID: 35173238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
    Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
    OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
    Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
    Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of MicroRNAs in Parkinson's Disease.
    Goh SY; Chao YX; Dheen ST; Tan EK; Tay SS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31718095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
    Ketprasit N; Cheng IS; Deutsch F; Tran N; Imwong M; Combes V; Palasuwan D
    Malar J; 2020 Aug; 19(1):285. PubMed ID: 32778117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
    O'Farrell HE; Bowman RV; Fong KM; Yang IA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease.
    Han SA; Jhun BW; Kim SY; Moon SM; Yang B; Kwon OJ; Daley CL; Shin SJ; Koh WJ
    Sci Rep; 2020 Feb; 10(1):3178. PubMed ID: 32081976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of gut miRNAs in idiopathic Parkinson's disease.
    Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T
    Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating microRNAs as biomarkers of adult Crohn's disease.
    Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples.
    Serafin A; Foco L; Blankenburg H; Picard A; Zanigni S; Zanon A; Pramstaller PP; Hicks AA; Schwienbacher C
    BMC Res Notes; 2014 Oct; 7():715. PubMed ID: 25304816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease.
    Ghanbari M; Darweesh SK; de Looper HW; van Luijn MM; Hofman A; Ikram MA; Franco OH; Erkeland SJ; Dehghan A
    Hum Mutat; 2016 Mar; 37(3):292-300. PubMed ID: 26670097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis.
    Liu L; Zhang J; Wu M; Xu H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):443. PubMed ID: 34530741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling.
    Xing RX; Li LG; Liu XW; Tian BX; Cheng Y
    Kaohsiung J Med Sci; 2020 Oct; 36(10):786-792. PubMed ID: 32492291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains.
    Dobricic V; Schilling M; Farkas I; Gveric DO; Ohlei O; Schulz J; Middleton L; Gentleman SM; Parkkinen L; Bertram L; Lill CM
    Brain Commun; 2022; 4(6):fcac274. PubMed ID: 36382223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating exosomal microRNAs as biomarkers of colon cancer.
    Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
    PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.